The embodiment of the present invention provides a prefilled syringe containing frusemide whereby the risk of material loss and contamination are eliminated. The present syringe being prefilled contains the concentration and the amount of frusemide required for the treatment. Therefore, the present syringe is not required to be filled from the drug ampoules and so, there are no chances of the drug getting exposed to the atmospheric contaminants leading to infections and further to health complications. The present syringe avoids the risks of breakage and associated material loss. Also it does not require glass ampoules to be filled from and hence there are no risks of breakage of the said ampoules leading to material loss. Therefore the present syringe eliminates the risk of material loss and contamination.
